tiprankstipranks
Advertisement
Advertisement
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
PremiumThe FlyTaysha Gene Therapies announces inducement grant under Nasdaq listing rule
2M ago
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
Premium
Weekend Updates
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
2M ago
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
Premium
Ratings
Regulatory Clarity and Broad Rett Syndrome Opportunity Drive Taysha Gene Therapies Buy Rating and $10 Target
3M ago
Citizens JMP healthcare analysts hold an analyst/industry conference
PremiumThe FlyCitizens JMP healthcare analysts hold an analyst/industry conference
4M ago
FDA appoints Richard Pazdur as Director of CDER
Premium
The Fly
FDA appoints Richard Pazdur as Director of CDER
5M ago
Taysha Gene Therapies price target raised to $8 from $6 at Citizens JMP
Premium
The Fly
Taysha Gene Therapies price target raised to $8 from $6 at Citizens JMP
5M ago
Taysha Gene Therapies Amends Sales Agreement, Expands Offering
PremiumCompany AnnouncementsTaysha Gene Therapies Amends Sales Agreement, Expands Offering
5M ago
Taysha Gene Therapies reports Q3 EPS (9c), consensus (9c)
Premium
The Fly
Taysha Gene Therapies reports Q3 EPS (9c), consensus (9c)
5M ago
Taysha Gene Therapies sees cash runway into 2028
Premium
The Fly
Taysha Gene Therapies sees cash runway into 2028
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100